Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis

Summary

This is a controlled study to determine the effectiveness and safety of MB12066 in the treatment of adult patients with Nonalcoholic Fatty Liver Disease(NAFLD) except cirrhosis.

Timeline

Start

2013-01

Primary completion

2014-11

Completion

2014-11

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment”

Drugs

Indications